FDA Issues Guidance On Trials For Stroke-Treatment Devices
This article was originally published in The Gray Sheet
Executive Summary
Neurothrombectomy device trials should be designed to show that stroke patients are more likely to have a good outcome with the device than with an established therapy, FDA advises in a June 18 guidance